GNH USA

Europe — EMA

Mecolzin

GNH USA supplies Mecolzin (Mesalazine), a 5‑aminosalicylic acid derivative for ulcerative colitis and Crohn’s disease. Request a quote for global supply.

Mesalazine

Request sourcing

1
Pack/s

What is Mesalazine?

Mesalazine, the active ingredient in Mecolzin, is a 5‑aminosalicylic acid (5‑ASA) derivative presented as an oral formulation for oral use. It is employed to reduce inflammation in the colon of patients with ulcerative colitis and Crohn’s disease. The drug acts locally in the gastrointestinal tract, delivering anti‑inflammatory effects while minimizing systemic exposure.

GNH USA supplies Mecolzin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide.

What is Mesalazine used for?

Mecolzin (mesalazine) is used to treat inflammatory bowel disease by targeting colonic inflammation.

- Ulcerative colitis: induces and maintains remission of symptoms and mucosal healing. - Crohn's disease: helps control disease activity when the colon is involved. - Maintenance therapy: reduces relapse rates in patients with previously controlled ulcerative colitis.

What are the side effects of Mesalazine?

Mecolzin may cause a range of adverse reactions.

Common Side Effects: - Nausea - Abdominal pain - Headache - Rash

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Pancreatitis - Interstitial nephritis

What precautions apply to Mesalazine?

Before prescribing Mecolzin, clinicians should consider several safety measures.

- Monitor renal function: assess baseline and periodic kidney tests. - Monitor hepatic function: check liver enzymes regularly. - Assess disease activity: ensure appropriate indication before use. - Avoid use in patients with known hypersensitivity to mesalazine or other salicylates. - Store at ambient temperature: keep in the original container, protect from moisture and light.

What does Mesalazine interact with?

Mecolzin can interact with other medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Sulfasalazine: additive gastrointestinal toxicity.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase renal toxicity. - Azathioprine or 6‑mercaptopurine: heightened risk of bone‑marrow suppression. - Diuretics: potential impact on renal function.

Frequently asked questions

What is Mecolzin used for?+
Mecolzin contains mesalazine, which is prescribed to treat inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease. It works by reducing inflammation in the colon, helping to achieve remission and maintain symptom control in affected patients.
How does mesalazine work in the body?+
Mesalazine releases 5‑aminosalicylic acid directly in the colon where it blocks cyclooxygenase and lipoxygenase enzymes, lowering prostaglandin and leukotriene production. It also neutralises free radicals, collectively diminishing the inflammatory response of the intestinal mucosa.
What is the usual dose of Mecolzin?+
The specific dose of Mecolzin is determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. Dosage regimens are individualized and should follow the prescriber’s instructions and local prescribing guidelines.
Is Mecolzin safe to use during pregnancy or breastfeeding?+
Safety data for mesalazine in pregnancy and lactation are limited, and the product’s pregnancy category is listed as unknown. Clinicians should weigh potential benefits against risks and consider alternative therapies when treating pregnant or nursing patients.
How do I order Mecolzin from GNH USA?+
To order Mecolzin, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.
How does Mecolzin compare with other 5‑ASA drugs?+
Mecolzin delivers mesalazine, the same active moiety found in other 5‑ASA products. Differences may lie in formulation, release characteristics, and dosing convenience. Clinicians choose a specific product based on patient tolerance, required dosing frequency, and cost considerations.
What are the storage requirements for Mecolzin?+
Mecolzin should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.
How is Mecolzin administered?+
Mecolzin is taken orally, usually as tablets or capsules, with or without food as directed by the prescriber. The medication should be swallowed whole with water and not crushed or chewed unless specifically instructed.
What are the most serious risks associated with Mecolzin?+
Serious risks, though rare, include severe allergic reactions such as anaphylaxis, pancreatitis, and interstitial nephritis. Patients should be monitored for signs of these conditions and seek immediate medical attention if symptoms develop.
Who should not use Mecolzin?+
Mecolzin is contraindicated in individuals with known hypersensitivity to mesalazine, other 5‑ASA compounds, or salicylates. It should also be avoided in patients with severe renal or hepatic impairment unless a specialist determines that benefits outweigh the risks.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Mesalazine
Route
Oral Use
Manufacturer
Innovis Pharma
Origin
EU

Related products